NTRK3 mutation in secretory carcinoma of the parotid gland: A Case report
Fahad AlKaabba, Abdurahman Alloghbi, Yazeed Deajim and 3 more
Clinical Case Reports · 2022
doi:10.1002/ccr3.6243 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Mammary analog secretory carcinoma (MASC) is a newly described carcinoma with a molecular hallmark of ETV6‐NTRK3 fusion that promotes oncogenesis. While MASC histopathology was well‐studied in the literature, clinical behavior remains unstudied. We present a 22‐year‐old man with painless parotid mass, which was diagnosed as salivary gland cancer, MASC subtype.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.